MicroRNA-155 Is Required for Effector CD8( ) T Cell Responses to Virus Infection and Cancer
Jan C Dudda, Bruno Salaun, Yun Ji, Douglas C Palmer, Gwennaelle C Monnot, Estelle Merck, Caroline Boudousquie, Daniel T Utzschneider, Thelma M Escobar, Rachel Perret, Stefan A Muljo, Michael Hebeisen, Nathalie Rufer, Dietmar Zehn, Alena Donda, Nicholas P Restifo, Werner Held, Luca Gattinoni, Pedro Romero
Immunity | CELL PRESS | Published : 2013
Awarded by NATIONAL CANCER INSTITUTE
Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
We thank D. Labes for technical assistance and I. Luescher for providing tetramers. We also thank P. Martiat and B. Badran for critical input. J. C. D. and B. S. were supported in part by a grant from the MEDIC Foundation, R. P. by New Zealand Foundation for Research, Science and Technology, W. H. and C. B. by the Swiss National Science Foundation (SNSF). G. C. M., D. Z., and P. R. were supported in part by a Prodoc and a Sinergia grants from the SNSF. Y. J., D. C. P., N. P. R. and L. G. were supported by the Intramural Research Programs of the US NIH National Cancer Institute, Center for Cancer Research. T. M. E. and S. A. M. were supported by the Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases.